StonvexLoading…
StonvexStonvexStonvexCore line items from LFMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $50.16M | $194.06M | $186.98M | $126.80M |
Operating Income | $-8.93M | $-7.67M | $-1.45M | $522.78K |
Net Income | $-8.87M | $14.35M | $-5.61M | $-1.80M |
EPS (Diluted) | $-0.20 | $0.25 | $-0.18 | $-0.08 |
Total Assets | $70.12M | $70.41M | $65.98M | $73.56M |
Total Liabilities | $55.09M | $47.25M | $62.62M | $73.18M |
Cash & Equivalents | $34.48M | $36.79M | $23.79M | $36.23M |
Free Cash Flow OCF − CapEx | $339.45K | $6.41M | $9.85M | $10.79M |
Shares Outstanding | 47.53M | 46.66M | 46.58M | 45.04M |